Vornia designs, develops and fabricates customised biomaterial solutions for medical device manufacturers and providers who need to add differentiation to their products in the marketplace.


November 8th, 2017

LRQA Surveillance Audit

We are happy to announce that Vornia’s ISO 13485 certification has been extended following a successful Surveillance Audit performed by Lloyd’s Register Quality Assurance (LRQA)of Vornia Ltd. on November 6-7, 2017. Vornia will continue to design and develop biomaterials including collagen and bioresorbable polymers in various forms for use in medical devices and medical technologies as well as manufacture and supply bioresorbable polymers in various forms for use in medical devices and medical technologies.


February 1st, 2017

3D-NEONET Consortium Meeting

University College Dublin (UCD) announced that it started to lead a new international industry-academia consortium to accelerate the development of therapeutic interventions for cancer and eye disease through enhanced intersectoral and transnational research cooperation.

The Drug Discovery and Delivery Network for Oncology and Eye Therapeutics (3D-NEONET) consortium has been awarded €945,000, over 4 years, under the European Union’s Horizon 2020 programme, Marie Skłodowska-Curie Research and Innovation Staff Exchange (MSCA-RISE). The consorium has brought together a unique group of microbiologists, cancer biologists, chemists, material scientists, mechanical engineers, ocular pharmacologists, geneticists and toxicologists from 9 academic and 9 non-academic partner organisations in 7 countries.


June 30th, 2016

UKSB Conference

Vornia sponsored and attended the very sucessful UK Society for Biomaterials(UKSB) conference event held in Westminister, London. Vornia’s Sean McMahon and Patrick Duffy presented a trade stand of Vornia’s product portfolio at this event. Vornia’s senior scientist Sean McMahon gave a presentation on Bio-absorbable polymers as part of the Science for Industry ReBioStent session.





November 25th, 2015

Relocation of Vornia Limited to the Synergy Centre, IT Tallaght

Vornia Limited moved premises from its current location in The Business Innovation Centre, NUI Galway, to its new facility: Synergy Centre, Laboratory A, Institute of Technology, Tallaght, Dublin 24, D24 A386. Vornia will officially take residence in its new facility beginning 25th November 2015 and will conduct business as usual. Our new telephone number is + 353 (0)1 531 2981 and our email details will remain intact. These are exciting times for Vornia and we look forward to continuing to work you in 2016.


August, 2015

Renewal of Vornia’s ISO 13485 Accreditation

Vornia Ltd. is proud to announce the renewal of its ISO 13485 Accreditation for the manufacture and supply of medical grade biomaterials for use in medical devices and technologies in August 2015. Vornia will continue manufacturing to the highest quality standards in our new premises in Dublin in 2016. We look forward to continued work with our customers, suppliers and business associates.


October, 2014

Vornia is Awarded ISO 13485:2012 Certification

Vornia has just received formal notification that it has been awarded registration to the International ISO 13485:2012 Standard for its Quality Management System. ISO 13485 is an internationally recognised standard, originally published in 2003 and revised in 2012, that sets out the requirements for a comprehensive quality management system for the design and manufacture of medical devices This standard is a highly coveted award for companies operating in the medical device industry and almost a pre-requisite for placing a CE approved medical device on the market.


Vornia Present at the IMDA European Research Funding Conference – Horizon 2020

Pictured (l-r): Brendan Gaffney (Boston Scientific); Sinead Keogh (IMDA); Colm O’Dowd (Vornia Ltd.); Sonia Ramirez-Garcia (DePuy Ireland) and Fergal Donnelly (European Commission).

Vornia presented to over 150 participants who gathered in Galway recently to explore new European funding opportunities for medical technology research and development. The conference jointly hosted by Enterprise Ireland and the Irish Medical Devices Association (IMDA) included IMDA members, academics and other research and regulatory bodies associated with the medical devices industry in Ireland.

The day long programme was designed to highlight the possibilities for Ireland under the Horizon 2020 programme – a €70 billion research funding programme which has recently been approved by the European Commission. The programme runs from 2014 – 2020 during which time SMEs and researchers in Ireland are expected to attract up to €1billion to fund world-class research. In the previous programme (FP7), Ireland attracted more than €600 million.  According to Dr Fergal Donnelly, speaking on behalf of the European Commission, the Horizon 2020 programme will place a greater emphasis on translational research and is focused on converting cutting edge research emerging from the academic institutions into innovative clinical solutions. He highlighted the importance of the SME sector in translating the early-stage research along the Technology Readiness Level (TRL) scale.

Vornia had been very successful in gaining EU FP7 funding and is working with partners in 6 consortia to develop innovative biomaterials based medical devices in clinical niche areas including tendon repair, soft tissue repair, nerve repair and stent coating development. It collaborates with several other medical device companies and supplies biomaterial including bioresorbable polymers and collagen to clients in Europe, the Middle East, China and America.   Vornia currently has 9 researchers working at its research laboratories and offices based in the Business Innovation Centre at NUI Galway.


June 18th, 2013

Vornia Presents at EuroNanoForum2013 Conference in Dublin

The CEO of Vornia, Dr. Colm O’Dowd, presented the work of the company the NanoNet Ireland Showcase http://www.euronanoforum2013.eu/nanonet-ireland-showcase/ which kicked off in Dublin yesterday as part of the EuroNanoForum2013. The NanoNet Showcase, which was organised by Enterprise Ireland and CCAN, provided a forum for established and emerging companies and service providers in Ireland to demonstrate their skills and abilities in the growing nanotechnology sector. There was a total of 1700 academic and industry staff attending from all sectors of the global nanotechnology sector converging at the National Conference Centre  for the event.  Vornia is working on a number of EU FP7 projects associated with nanotechnology including the Green NanoMesh (http://www.greennanomesh.com/overview/) and Tendon Regeneration projects (http://www.tendon-regeneration.com/overview/). The event concludes tomorrow.


Irish Times October 9th, 2012

Vornia involved in study to ‘camoflage’ stents in body

A new study which is led by researchers in Galway is looking to “camouflage” implanted stent devices in the body to reduce long-term complications. The EU-funded project aims to produce a stent coated with molecules that will encourage cells to grow on the device and stop the immune system from recognising it as “foreign”.

Read the full article by Claire O’Connell here


Irish Times August 23rd, 2012

Flexible visa procedures put search for talent first

Immigration is always a thorny subject and it often leads to very polarised opinions. In the area of research the international flow of people is a necessary condition for excellence. The most successful countries in the world have always operated an open system for attracting researchers, notable examples being the US and the UK.

Read the full article by Conor O’Carroll here